Treatment with semaglutide and papaya significantly reduced hyperglycemia and improved the lipid profile
Saatman KE, Contreras PC, Smith DH, Raghupathi R, McDermott KL, Fernandez SC, et al
sema, semaglutide
Can enhancing melatonin in middle-age, when the decline begins, slow the accumulation of oxidative damage and reduce the incidence of neurodegenerative disease decades later
Suggested Use / Directions: Take 1 or more teaspoons Daily as recommended by a health care professional
et al., The increasing rate of diabetes in Pakistan: A silent killer (2022) IDF, Prevalence of Diabetes in Pakistan (2024) Jastreboff et al., NEJM, Phase 2 obesity trial of retatrutide (2023) Reuters Next generation Lilly weight-loss drug shows added heart, liver benefits (2024) Investopedia / news20 Eli Lilly shares rise after drug helps patients lose more weight than competitors (2023) Lancet Phase 2 trial on T2DM (via ResearchGate summary) PMC meta-analysis: weight/metabolic outcomes of retatrutide Anti-obesity medication (retatrutide entry) News21 (Axios) Extraordinary promise of retatrutide (2023) USA Today (American Diabetes Association summary) News25 (NY Post) re: Phase 3 status and side effects
